Has FDA issued a warning letter to Chemistry Rx?

No FDA warning letter, Form 483, or inspection classification naming Madame Rx, LLC dba Chemistry Rx was found in the public FDA databases checked. FDA inspects 503A pharmacies only for cause, so absence of a record is not a clearance.

503A state-licensed compounding pharmacy

Chemistry Rx

Madame Rx, LLC dba Chemistry Rx, 950 Henderson Blvd, Folcroft, Pennsylvania. Public-record profile of a pharmacy that fills telehealth prescriptions; records checked 10 September 2026.

503Aregistration type

0public regulatory records

Nopublished BUD or testing policy

1providers naming it

Which telehealth providers use Chemistry Rx

One telehealth provider in the Telehealth Ledger directory names Chemistry Rx as a fulfillment pharmacy on its own public pages: BraveRX. Each name below links to that provider's profile, where the pharmacy statement sits beside its dated source.

BraveRX's pharmacy disclosure, as recorded in its dossier: Quoted from BraveRX's terms: "Madame Rx LLC, 950 Henderson Blvd., Folcroft, PA 19032, doing business as Chemistry Rx".

Naming a pharmacy does not mean every prescription goes there. Most telehealth services list several partners and route each order by medication, state licensure, and stock, so the pharmacy on your label can differ from the marketing page. The vial label is the authoritative record of who compounded and dispensed it.

BraveRX

503A vs 503B compounding pharmacy: what it means for your prescription

Chemistry Rx is recorded here as a 503A compounding pharmacy. Its investor Pine Tree Equity's March 2021 recapitalization announcement says Chemistry Rx operates a 503A pharmacy, NPPES records Pennsylvania pharmacy license RP038763L for Madame Rx, LLC, and the pharmacy does not appear on FDA's registered outsourcing facility list (checked 2026-09-10).

A 503A pharmacy compounds a patient-specific prescription and is licensed and inspected primarily by its state board of pharmacy; it does not register with FDA as an outsourcing facility and is not required to follow federal current good manufacturing practice (CGMP). Compounded semaglutide or tirzepatide from a 503A pharmacy is not an FDA-approved product, and the beyond-use date on the label comes from the pharmacy's own stability practice under USP standards rather than from an approved drug application.

FDA inspection history and public regulatory records

No FDA warning letter, Form 483 observation list, inspection classification, or state board action naming Madame Rx, LLC dba Chemistry Rx was found in the public databases checked on 10 September 2026. That is a statement about the search, not a clearance: FDA inspects 503A pharmacies only for cause or on referral, so most state-licensed compounders have no federal record at all, and state board actions are held in separate state systems.

Databases checked: FDA registered outsourcing facilities list (updated 2026-09-08) (no record found); FDA compounding inspections, recalls, and other actions (no record found).

If a new letter, action, or recall appears, it is added with its date and primary link and earlier summaries are not rewritten.

State pharmacy license and accreditation

NPPES (Pennsylvania pharmacy license) lists Madame Rx, LLC dba Chemistry Rx under license RP038763L with the status "recorded in the NPPES entry for NPI 1164779617; the state board's own status was not separately checked" when checked on 10 September 2026. A resident license in Pennsylvania covers dispensing from that address; shipping to patients in other states requires a separate non-resident pharmacy license in each of those states, which is why provider availability lists change by state.

No NABP accreditation (PCAB, Digital Pharmacy, or similar) was found listed for this pharmacy on the dates checked. Accreditation is voluntary and its absence is not a finding.

NPPES (Pennsylvania pharmacy license) license record

Beyond-use date (BUD) and testing policy

Chemistry Rx does not publish a beyond-use date policy, stability study, or testing statement on the public pages checked. Many compounding pharmacies share this only with the prescribing provider or on request, so "not found" describes the public website, not the pharmacy's records.

A beyond-use date (BUD) is the date after which a compounded preparation must not be used; the pharmacy assigns it under USP <797> sterile compounding standards and prints it on the dispensing label. It is not the same as a manufacturer's expiration date on a brand pen. Follow the storage and BUD printed on your pharmacy label; if a vial arrives without one, ask the dispensing pharmacy before use.

How compounded GLP-1 medication is shipped from this pharmacy

Chemistry Rx does not publish a patient-facing shipping or cold-chain statement on the pages checked, so the shipping promises below come from the telehealth providers that route orders to it.

Provider shipping claims: BraveRX says Quoted from BraveRX's FAQ: "BraveRX typically ships within 48 hours".

Compounded semaglutide and tirzepatide ship refrigerated: an insulated box with cold packs, usually by an overnight or two-day carrier service on weekdays so a package is never in transit over a weekend. On arrival, put the vial in the refrigerator, check the label for the BUD and storage line, and contact the pharmacy if the cold pack is fully thawed or the vial is warm.

Verification notes

The pharmacy's accreditation page lists PCAB accreditation through ACHC with a stated scope of USP 795 and 800 non-sterile compounding, ACHC specialty pharmacy accreditation, and an NABP Healthcare Merchant accreditation, and says the pharmacy is licensed in all 50 states with 25 additional Medicaid licenses. These are the pharmacy's statements; the accrediting bodies' directories were not checked.
The pharmacy's contact and welcome pages describe free standard UPS shipping in 2 to 3 business days and a flat $20 to $25 overnight charge for refrigerated items in temperature-maintaining packaging. The pharmacy says its ingredients come from FDA-registered manufacturers; no testing or BUD policy is published.
NPPES lists the pharmacist in charge as Amany Farid Mansour-Awad, RPh.
A separate Folcroft firm, Nexgen Formulations, registered as a 503B outsourcing facility on 2026-01-15; no link to Chemistry Rx was found.

Questions about Chemistry Rx

Is Chemistry Rx a 503A or 503B pharmacy?: Chemistry Rx is recorded as a 503A state-licensed compounding pharmacy. Its investor Pine Tree Equity's March 2021 recapitalization announcement says Chemistry Rx operates a 503A pharmacy, NPPES records Pennsylvania pharmacy license RP038763L for Madame Rx, LLC, and the pharmacy does not appear on FDA's registered outsourcing facility list (checked 2026-09-10).
Has FDA issued a warning letter to Chemistry Rx?: No FDA warning letter, Form 483, or inspection classification naming Madame Rx, LLC dba Chemistry Rx was found in the public FDA databases checked. FDA inspects 503A pharmacies only for cause, so absence of a record is not a clearance.
Which telehealth providers use Chemistry Rx?: BraveRX name Chemistry Rx on their public pages. Assignment can vary by medication, state, and stock; the dispensing label shows the pharmacy that filled your order.

Sources

Every statement above links to the public record it came from, checked on the date shown. “Not found” describes that search, not the pharmacy. For the full process from consult to refrigerator, read how the medication reaches you.